IJSTR

International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us
CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT
QR CODE
IJSTR-QR Code

IJSTR >> Volume 2- Issue 5, May 2013 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Primary Hypogonadism In Ghanaian Men With Type 2 Diabetes Mellitus

[Full Text]

 

AUTHOR(S)

H. Asare-Anane, E.K. Ofori, F.A.Yeboah, E.A. Tagoe, S.B. Bani, A.T. Bawah, R.O Ateko

 

KEYWORDS

Keywords- Diabetes, Estradiol, Glycated hemoglobin, Hypogonadism, Insulin, Obesity, Prolactin,

 

ABSTRACT

Abstract-Emerging evidence links insulin resistance, a key feature in type 2 diabetes with decreased leydig cell secretion of testosterone. Low gonadal steroids, which include testosterone, dihydrotestosterone and estradiol have also been implicated with metabolic abnormalities such as hyperglycemia, hypertension and cardiovascular risk. The aim of this study was to investigate hypogonadism and its risk factors in Ghanaian men with type 2 diabetes. Two hundred and ten volunteers were used for this study. Total testosterone, Sex hormone binding globulin, prolactin, fasting blood glucose, glycated hemoglobin, total cholesterol, triglyceride, luteinizing hormone, follicle stimulating hormone, estradiol, blood pressure and body mass index were assessed. A questionnaire to assess androgen deficiency was administered to each consenting participant. Total testosterone levels were lower in diabetic men compared with non-diabetic men (10.8 ± 5.0 vs 15.6 ± 3.9, p=0.0001). There was no significant change in follicle stimulating hormone, prolactin, sex hormone binding globulin and estradiol between controls and type 2 diabetics. However, luteinizing hormone was significantly higher in diabetics than non-diabetics (5.4±2.0 vs 4.5±1.5 p≤0.0003). Total testosterone levels were inversely related to BMI (R2=3.94, p=0.04), FBG (R2=6.492, p=0.0008) and TG (R2=31.41, p=0.025). The low testosterone observed in this study was a case of primary hypogonadism.

 

REFERENCES

[1]. E. Nieschlag, H.M. Behre, P. Bouchard, J.J. Corrales, T.H. Jones, G.K. Stalla, S.M. Webb, F.C.W. Wu, Testosterone replacement therapy: current trends and future directions. Hum Reprod Update; 5:409–411, 2004

[2]. D. Kapoor, E, Goodwin, K.S. Channer, T.H. Jones, Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol; 154(6):899–906, 2006

[3]. B.D Anawalt, N.N. Grant, Male hypogonadism in the primary care clinic. Prim Care Dec; 30:743-763, 2003

[4]. N. Pitteloud, M. Hardin, A.A. Dwyer, E. Valassi, M. Yialamas, D. Elahi, F.J. Hayes, Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab; 90(5):2636-2641, 2005

[5]. C. Christina

[6]. F.F.G. Rommerts, Testosterone: an overview of biosynthesis, transport, metabolism and non-genomic actions. In: Testosterone, Action, Deficiency, Substitution. Behre HM, Ed. Cambridge, Cambridge University Press, p. 1–38, 2004

[7]. Oh, J.Y., Barrett-Conner, E., Wedick, N.M., Wingard, D.L., (2002). Endogenous sex hormones and the development of type 2 diabetes in older men and women. Diabetes Care; 25(1):55-60.

[8]. R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, J.B. McKinlay, Testosterone, sex hormone-binding globlin, and the development of type 2 diabetes in middle-aged men. Diabetes Care; 23(4): 490-494, 2000

[9]. G.B. Phillips, T.Y. Jing, L.M. Resnick, M. Barbagallo, M., J.H Laragh, J.E. Sealey, Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. Journal of Hypertension; 11(7):699-702, 1993

[10]. D. Kapoor, H. Aldred, S. Clark, K.S. Channer, T.H. Jones, Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes. Diabetic Care; 30(4):911-917, 2007

[11]. S. Bhasin, G.R. Cunningham, F.J. Hayes, A.M.Matsumoto, P.J.Snyder, R.S. Swerdloff, V,M Montori, Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab; 91(6):1995-2010, 2006

[12]. S. Dhindsa, S. Prabhakar, M. Sethi, A. Bandyopadhyay, A. Chaudhuri, P. Dandona, Frequent occurrence of hypogonadotrophic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab; 89(11):5462-5468, 2004

[13]. G. Hackett, N.S. Cole, A.A. Deshpande, M.D. Popple, D. Kennedy, P. Wilkinson, Biochemical hypogonadism in men with type 2 diabetes in primary care practice. Br J Diabetes Vasc Dis; 9:226-231, 2009

[14]. J.M. Kaufman, A. Vermeulen, The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews; 26(6):833-876, 2005

[15]. D. Kapoor, C.J. Malkin, K.S. Channer, T.H. Jones, Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf); 63(3):239 –250. 2005

[16]. S.M. Haffner, P. Karhapaa, L. Mykkanen, M. Laakso, Insulin resistance, body fat distribution and sex hormones in men. Diabetes; 43: 12-19, 1994

[17]. E.L. Ding, Y. Song, V.S. Malik, S. Liu, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA; 295(11):1288-1299, 2006

[18]. T.C. Chang, C.C. Tung, Y.L. Hsiao, Hormonal changes in elderly men with non insulin dependent diabetes mellitus and the hormonal relationships to abdominal adiposity. Gerontology; 40:260-267, 1994

[19]. P.G. Cohen, Aromatase, adiposity, aging and disease: the hypogonadal-metabolic-atherogenic-disease and age connection. Medical Hypthesis; 56(6):702-708, 2001

[20]. P. Marin, S. Arver, Androgens and abdominal obesity. Bailliere’s Clinical Endocrinology; 12:441-451, 1998

[21]. E.C. Tsai, E.J. Boyko, D.L. Leonetti, W.Y. Fujimoto, Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. International Journal of Obesity and Related Metabolic Disorders; 24:485-491, 2000

[22]. A. Vermeulen, Decreased androgen levels and obesity in men. Ann Med; 28(1):13-15, 1996

[23]. P. Bjorntorp, The regulation of adipose tissue distribution in humans. International Journal of Obesity and Related Metabolic Disorders; 20(4):291-302, 1996